Countries affected
Visit our COVID-19 microsite for the latest coronavirus news, analysis and updates GlobalData's latest Coronavirus Influencers…
Covid-19
Coronavirus
-
Global confirmed cases33,381,728
-
Global deaths444,248
-
Global death rate1.33%
-
Global recoveries30,974,748
-
Global recovery rate92.79%
-
Global confirmed cases33,381,728
-
Global deaths444,248
-
Global death rate1.33%
-
Global recoveries30,974,748
-
Global recovery rate92.79%
Coronavirus COVID-19 outbreakLatest news, information and updates
As the coronavirus spreads globally we track the confirmed cases, deaths, recoveries through this microsite, dedicated to Covid-19 updates. The microsite also provides insights into the international spread and social media reaction, alongside a coronavirus FAQ and all the latest news and information concerning the outbreak.
What you need to know
Suspected Cases
Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates Follow the updates…
Social media tracker
Coronavirus Social Media Dashboard Pharmaceutical companies are in the spotlight as they race to develop…
Frequently asked questions
Answers to some of the most popular FAQs on coronavirus outbreak and COVID-19
Side-by-side comparison
Total cases vs total recovered patients vs total deaths.
Side-by-side comparison
COVID-19 is a global pandemic, with China accounting for a small share of cases
Coronavirus Blog
View MoreLatest on Coronavirus
View More
Lilly’s Covid-19 antibody combo EUA expands for post-exposure prophylaxis
The US Food and Drug Administration (FDA) has updated the Emergency Use Authorization (EUA) for Eli Lilly’s bamlanivimab plus etesevimab to include post-exposure prophylaxis in…
Health Canada grants full approval to Moderna and Pfizer Covid-19 shots
Health Canada has granted full approval to Moderna and Pfizer-BioNTech Covid-19 vaccines, Spikevax (elasomeran mRNA vaccine) and Comirnaty respectively for use in people aged 12…
US to buy additional doses of Lilly’s Covid-19 antibody therapies
The US Government is to purchase additional doses of Eli Lilly’s neutralising antibody therapies authorised for emergency use to treat Covid-19. Under the deal, Lilly…
Glenmark completes PMS study of Covid-19 drug Favipiravir
India-based Glenmark Pharmaceuticals has concluded the post-marketing surveillance (PMS) study of its oral antiviral drug, Favipiravir (FabiFlu), in mild to moderate Covid-19 patients in the…
US to procure 1.4 million doses of Regeneron’s antibody cocktail
The US Department of Health and Human Services (HHS) and the Department of Defense (DOD) have entered an agreement with Regeneron Pharmaceuticals to procure 1.4 million additional doses of…
RedHill’s opaganib fails to meet Phase II/III Covid-19 trial primary goal
RedHill Biopharma has reported initial top-line results where its investigational drug, opaganib (ABC294640), failed to meet the primary goal in the global Phase II/III clinical…
